世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の眼科治療薬とデバイス市場予測 2018-2026年

GLOBAL OPTHALMOLOGY DRUGS AND DEVICES MARKET FORECAST 2018-2026

 

出版社 出版年月電子版価格 ページ数
Inkwood Research
インクウッドリサーチ
2018年5月US$2,500
シングルユーザライセンス
150

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

サマリー

この調査レポートは世界の眼科治療薬とデバイス市場を分析・予測したInkwood Researchの市場調査報告書です。

Description

KEY FINDINGS
The global ophthalmic drugs and device market is expected to grow at a CAGR of 5.97% over the forecast period of 2018-2026. The rising eye-related disorders in the world, changing lifestyle, and rising healthcare expenditure are the major driving factors in the growth of the global ophthalmic drug and devices market.
MARKET INSIGHTS
The global ophthalmic drugs and devices market is segmented on the basis of the type of devices and type of drugs. The devices are sub-segmented into diagnostic and monitoring equipments, surgery devices, and vision care devices. The drugs segment of the market includes glaucoma drugs, retinal disorder drug, dry eye drug, inflammation, allergic conjunctivitis, and conjunctivitis drugs and drugs by use of preservation. Well-known drugs are going off patent, and key players affected by the delay in new drugs coming into the market are the two factors restricting the growth of the market. The market faces challenges in risk associated with the ocular diseases and lack of awareness among people regarding ophthalmology.
REGIONAL INSIGHTS
Geographically, the global ophthalmic drugs & devices market is segmented into North America, Europe, Asia-Pacific, and Rest of World. Currently, North America holds a massive market share followed by Europe and Asia-Pacific. Due to rising geriatric population, increase in strategic initiatives by large market players present in the region and increasing prevalence of ocular diseases, the North America ophthalmic drugs & devices market holds high growth prospects for the near future. However, over the forecasted period, the Asia-Pacific market is expected to grow with the highest CAGR. APAC market is majorly driven by the rising prevalence and increasing facilities for eye treatment in hospitals.
COMPETITIVE INSIGHTS
Allergan Inc, Bayer, Carl Zeiss Ag, Essilor International S.A, GlaxoSmithKline, Johnson & Johnson Inc, Novartis International Ag, Pfizer, Roche Holding Ag, Santen Pharmaceutical Co Ltd, Sun Pharmaceuticals Industries Ltd, Valent Pharmaceuticals International Inc and Ziemer Group Holding Ag are few of the noted companies in the global ophthalmology drugs and devices market.



目次

目次はEメールでお送りいたします。データリソースまでお申し付けください。

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る